Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- DOI
- 10.1038/s41467-023-40061-y
- Published
- 2023 Jul 24
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-023-40061-y,
title = {Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.},
author = {Coombes RC and Howell S and Lord SR and Kenny L and Mansi J and Mitri Z and Palmieri C and Chap LI and Richards P and Gradishar W and Sardesai S and Melear J and O'Shaughnessy J and Ward P and Chalasani P and Arkenau T and Baird RD and Jeselsohn R and Ali S and Clack G and Bahl A and McIntosh S and Krebs MG},
year = {2023},
journal = {Nature communications},
doi = {10.1038/s41467-023-40061-y},
url = {https://doi.org/10.1038/s41467-023-40061-y}
}RIS
TY - JOUR TI - Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib. AU - Coombes RC AU - Howell S AU - Lord SR AU - Kenny L AU - Mansi J AU - Mitri Z AU - Palmieri C AU - Chap LI AU - Richards P AU - Gradishar W AU - Sardesai S AU - Melear J AU - O'Shaughnessy J AU - Ward P AU - Chalasani P AU - Arkenau T AU - Baird RD AU - Jeselsohn R AU - Ali S AU - Clack G AU - Bahl A AU - McIntosh S AU - Krebs MG PY - 2023 JO - Nature communications DO - 10.1038/s41467-023-40061-y UR - https://doi.org/10.1038/s41467-023-40061-y ER -
APA
RC, C., S, H., SR, L., L, K., J, M., Z, M., C, P., LI, C., P, R., W, G., S, S., J, M., J, O., P, W., P, C., T, A., RD, B., R, J., S, A., G, C., A, B., S, M., & MG, K. (2023). Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.. Nature communications. https://doi.org/10.1038/s41467-023-40061-y
Source records
- pubmed · retrieved 2026-09-26T20:05:46.298Z